Truepill Raises $25M in Series B Funding
Summary
The company will use funds to expand adoption of its direct-to-patient healthcare solutions and continue growing its product offerings. Founded in 2016 by Umar Afridi, Co-founder and CEO, and Sid Viswanathan, Co-founder and President, Truepill leverages a B2B model which builds direct-to-patient experiences across the entire healthcare ecosystem, working with health plans, pharmaceutical manufacturers and consumer health brands alike. A URAC-accredited company, the company provides an API technology, nationwide pharmacy fulfillment and delivery services, a US-based network of licensed telehealth practitioners, white label product design and more. Truepill’s technologies and services are built to scale with every customer; its pharmacies have the capacity to deliver 100,000 prescriptions per day, and its US-based network of licensed physicians and nurse practitioners can diagnose and prescribe across 50 states. In addition to growing its B2B business, the company will continue to invest in its portfolio of consumer health brands.